期刊文献+

垂体大腺瘤手术前后垂体后叶高信号的变化 被引量:4

Posterior pituitary bright spot in large adenomas:change after operation
下载PDF
导出
摘要 目的观察垂体大腺瘤手术前后垂体后叶高信号的变化以及和尿崩症的关系。方法92例垂体大腺瘤患者根据术前MRIT1像垂体后叶是否显示高信号分成两组,分别比较两组的性别、年龄、肿瘤大小以及术后垂体后叶高信号出现的情况,同时比较手术后长期尿崩症出现和垂体后叶高信号显示的关系。结果92例中有60例(65.2%)显示垂体后叶高信号,32例(34.8%)未显示。肿瘤大小和垂体后叶高信号的出现有显著性差异(P=0.002),大腺瘤(直径1~3cm)出现和不出现的比例为40:10,而巨大腺瘤(直径﹥3cm)的比例为为20:22;垂体后叶高信号可见组中术后有5例消失,而垂体后叶高信号不可见组中有12例在术后显示。术后长期尿崩5例,其中4例垂体后叶高信号在术后无显示,与术后垂体后叶高信号显示的病例有显著性差异。结论垂体大腺瘤垂体后叶高信号的显示对于评价神经垂体的功能有帮助,肿瘤体积越大垂体后叶高信号出现的比例越小,术后垂体后叶高信号缺失者发生尿崩症的比例较高。 Objective To evaluate the disappearance or relocation patterns of posterior pituitary bright spot (PPBS) in large pituitary adenomas and relation to diabetes insipidus (DI). Methods ninety-two patients with large adenoma were classified into PPBS-visible and PPBS-invisible groups on the basis of findings at preoperative T1-weighted magnetic resonance (MR) imaging. The large adenoma were classified into macro adenoma (diameter 1-3cm) and giant adenoma ( 〉 3cm). Gender, age and PPBS changes after operation were compared. Post operation persisting DI was also analyzed based on PPBS-visible and tumor size. Results The PPBS-visibte group included 60 patients (65.2%) and 32 while patiend (34.8%) were in PPBS-invisble group find PPBS. There were no significant difference of gender and age between two groups. PPBS most commonly occurred in 40 patients with macro adenoma (40 of 50). In giant adenoma occurred in 20 (20 of 42). Postoperatively, 5 patients, in PPBS-invisible group became invisible.. The PPBS-invisible group included 12 (37.5%) patients became visible. Five patients developed postoperative permanent diabetes insipidus. In while four patients were PPBS-invisible in post operation MRI. It has significant difference. The tumor size and PPBS signal had no relationship with postoperation permanent DI in statistics. Conclusions The pituitary adenoma size can influence PPBS visible in MRI. Giant adenoma was more commonly nonvisible. And postoperation permanent DI is commonly occurred in PPBS-invisible patients in post operation MRI. The presence of PPBS in the infundibuloneurohypophyseal system indicates its functional maintenance in large adenomas.
出处 《北京医学》 CAS 2008年第10期600-603,共4页 Beijing Medical Journal
关键词 垂体腺瘤 垂体后叶高信号 尿崩症 Pituitary adenoma Posterior pituitary bright spot Diabetes insipidus
  • 相关文献

参考文献12

  • 1Colombo N, Berry I, Kucharczyk J, et al. Posterior pituitary gland: appearance on MR images in normal and pathologic states. Radiology, 1987, 165:481 -485. 被引量:1
  • 2李小宝,王学建,魏渝清,沈桂权,李东芳,史黔华,向志华,陈永平.正常成人垂体腺MRI研究[J].贵阳医学院学报,1999,24(2):119-121. 被引量:4
  • 3周环,唐桂波,郭建忠.高海拔地区成人正常垂体腺的MRI研究[J].实用放射学杂志,2001,17(2):89-91. 被引量:3
  • 4吕发金,张克随,吴景全,石军.垂体后叶MRI与电镜对照研究[J].中国医学影像技术,1998,14(9):648-650. 被引量:9
  • 5Sto N. Hemodialysis:relationship between signal intensity of the posterior pituitary gland at MR Imaging and level of plasma antidniretic hormone. Radiology, 1995, 194:277 - 280. 被引量:1
  • 6Erich S, Engelbert K, Christian J, et al. Pituitary Adenomas: Findings of Postoperative MR Imaging. Radiology 1992, 185: 521-527. 被引量:1
  • 7Fujisawa I, Kikuchi K, Nishimura K, et al. Transection of the pituitary stalk :development of an ectopie posterior lobe assessed with MR imaging. Radiology, 1987, 165:487 - 489. 被引量:1
  • 8Naokatsu S, Michihiro H, Hisayuki M, et al. Posterior Pituitary Bright Spot in Large Adenomas : MR Assessment of Its Disappear- mace or Relocation along the Stalk. Radiology, 2003, 226:359 - 365. 被引量:1
  • 9Ciric I, Ragin A, Pierce D. Complications of transsphenoidal surgery:results of a national survey, review of the literature and personal experience. Neurosurgery, 1997, 40:225 - 237. 被引量:1
  • 10吕发金,罗天友,石军,李咏梅,袁书伟,史斌.中枢性尿崩症的MRI研究[J].重庆医学,2001,30(6):489-491. 被引量:8

二级参考文献10

共引文献29

同被引文献52

  • 1Schreckinger M,Szerlip N,Mittal S.Diabetes insipidus following resection of pituitary tumors[J].Clin Neurol Neurosurg,2013,115(2):121-126. 被引量:1
  • 2Fenske W,Allolio B.Clinical review:Current state and future perspectives in the diagnosis of diabetes insipidus:a clinical review[J].J Clin Endocrinol Metab,2012,97(10):3426-3437. 被引量:1
  • 3Calabro RS,Italiano D,Ferrara D,et al.The hypothalamic-neurohypophyseal system:current and future treatment of vasopressin and oxytocyn related disorders[J].Recent Pat Endocr Metab Immune Drug Discov,2012,6(3):235-250. 被引量:1
  • 4Holt NF,Haspel KL.Vasopressin:a review of therapeutic applications[J].J Cardiothorac Vasc Anesth,2010,24(2):330-347. 被引量:1
  • 5Vincent JL,Su F.Physiology and pathophysiology of the vasopressinergic system[J].Best Pract Res Clin Anaesthesiol,2008,22(2):243-252. 被引量:1
  • 6Morgenthaler NG,Struck J,Jochberger S,et al.Copeptin:clinical use of a new biomarker[J].Trends Endocrinol Metab,2008,19(2):43-49. 被引量:1
  • 7Bellastella A,Bizzarro A,Colella C,et al.Subclinical diabetes insipidus[J].Best Pract Res Clin Endocrinol Metab,2012,26(4):471-483. 被引量:1
  • 8Pratheesh R,Swallow DM,Rajaratnam S,et al.Incidence,predictors and early post-operative course of diabetes insipidus in paediatric craniopharygioma:a comparison with adults[J].Childs Nerv Syst,2013,29(6):941-949. 被引量:1
  • 9Devin JK.Hypopituitarism and central diabetes insipidus:perioperative diagnosis and management[J].Neurosurg Clin N Am,2012,23(4):679-689. 被引量:1
  • 10Fenske W,Quinkler M,Lorenz D,et al.Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome-revisiting the direct and indirect water deprivation tests[J].J Clin Endocrinol Metab,2011,96(5):1506-1515. 被引量:1

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部